Immuron

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:12 PM UTC after-hours

Why Robinhood?

You can buy or sell Immuron and other stocks, options, and ETFs commission-free!

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.

CEO
Jerry Kanellos
Employees
Headquarters
Carlton, Victoria (VIC)
Founded
1994

IMRN Key Statistics

Market Cap
28.17M
Price-Earnings Ratio
Dividend Yield
Average Volume
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$28.99
52 Week Low
$1.92

IMRN Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected Aug 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure